Beyond its principal effects in glucose-decrease, this drug could reduce endothelial dysfunction, inducing nitric oxide production, activating cellular energy pathways, and reducing the expression of some inflammatory markers as Endothelin 1 (ET-1) (200, 201)
Semaglutide (the active ingredient in Ozempic and Wegovy) is a single GLP-1 receptor agonist
Given the controversial effect of androgen-based therapies, SARMs have emerged as a promising alternative
If you accidentally inject a large air bubble and experience sudden swelling, redness, or warmth spreading from the injection site, notify your provider the same day
What Phase 2 is not powered to do is detect rarer adverse events, confirm long-term safety, or establish outcomes over years of use